X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (73195) 73195
Newsletter (1601) 1601
Magazine Article (129) 129
Book Chapter (99) 99
Newspaper Article (69) 69
Dissertation (64) 64
Government Document (33) 33
Conference Proceeding (26) 26
Publication (24) 24
Web Resource (11) 11
Journal / eJournal (7) 7
Reference (7) 7
Streaming Video (7) 7
Report (6) 6
Book Review (5) 5
Book / eBook (4) 4
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (49350) 49350
female (36253) 36253
cyclophosphamide (30657) 30657
male (28296) 28296
middle aged (22628) 22628
adult (21731) 21731
cyclophosphamide - administration & dosage (20664) 20664
cyclophosphamide - therapeutic use (18176) 18176
antineoplastic combined chemotherapy protocols - therapeutic use (17261) 17261
oncology (17065) 17065
animals (15218) 15218
aged (15039) 15039
chemotherapy (11303) 11303
mice (9432) 9432
treatment outcome (9338) 9338
doxorubicin - administration & dosage (8805) 8805
hematology (8590) 8590
adolescent (7996) 7996
cancer (7954) 7954
vincristine - administration & dosage (7631) 7631
cyclophosphamide - pharmacology (7051) 7051
cyclophosphamide - adverse effects (6929) 6929
prognosis (6669) 6669
therapy (6257) 6257
combined modality therapy (6050) 6050
breast neoplasms - drug therapy (5893) 5893
child (5762) 5762
antineoplastic combined chemotherapy protocols - adverse effects (5498) 5498
drug therapy, combination (5439) 5439
antineoplastic combined chemotherapy protocols - administration & dosage (5276) 5276
transplantation (5024) 5024
prednisone - administration & dosage (4952) 4952
time factors (4900) 4900
retrospective studies (4896) 4896
rituximab (4629) 4629
immunosuppressive agents - therapeutic use (4618) 4618
care and treatment (4442) 4442
follow-up studies (4407) 4407
prednisone - therapeutic use (4341) 4341
vincristine - therapeutic use (4322) 4322
immunology (4193) 4193
rats (4144) 4144
research (3935) 3935
breast cancer (3847) 3847
doxorubicin (3800) 3800
methotrexate - administration & dosage (3777) 3777
disease-free survival (3759) 3759
child, preschool (3674) 3674
doxorubicin - therapeutic use (3639) 3639
drug administration schedule (3626) 3626
neoplasm staging (3558) 3558
remission induction (3544) 3544
antineoplastic agents - therapeutic use (3527) 3527
survival (3439) 3439
survival rate (3439) 3439
aged, 80 and over (3300) 3300
dose-response relationship, drug (3252) 3252
survival analysis (3218) 3218
fluorouracil - administration & dosage (3044) 3044
etoposide - administration & dosage (3034) 3034
pharmacology & pharmacy (2999) 2999
cisplatin - administration & dosage (2919) 2919
medicine, general & internal (2861) 2861
rheumatology (2860) 2860
medicine & public health (2850) 2850
analysis (2757) 2757
breast neoplasms - pathology (2711) 2711
risk factors (2682) 2682
health aspects (2524) 2524
young adult (2523) 2523
recurrence (2495) 2495
methotrexate - therapeutic use (2485) 2485
bone marrow transplantation (2418) 2418
prospective studies (2391) 2391
trial (2357) 2357
methotrexate (2280) 2280
vincristine (2256) 2256
lymphoma, non-hodgkin - drug therapy (2231) 2231
chemotherapy, adjuvant (2229) 2229
clinical trials as topic (2218) 2218
cyclophosphamide - toxicity (2210) 2210
disease (2202) 2202
immunosuppression (2158) 2158
lymphomas (2143) 2143
cisplatin (2136) 2136
antineoplastic agents - administration & dosage (2104) 2104
infant (2082) 2082
lymphoma, large b-cell, diffuse - drug therapy (2069) 2069
immunotherapy (2050) 2050
lung neoplasms - drug therapy (2044) 2044
toxicity (2029) 2029
hematopoietic stem cell transplantation (2023) 2023
drug therapy (2020) 2020
ovarian neoplasms - drug therapy (2014) 2014
doxorubicin - adverse effects (2011) 2011
stem cells (1960) 1960
leukemia (1930) 1930
patients (1916) 1916
children (1892) 1892
prednisone (1890) 1890
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (66355) 66355
German (2615) 2615
Japanese (2378) 2378
French (1537) 1537
Russian (1316) 1316
Chinese (836) 836
Spanish (735) 735
Italian (506) 506
Polish (423) 423
Portuguese (229) 229
Czech (108) 108
Korean (91) 91
Hungarian (79) 79
Dutch (73) 73
Danish (43) 43
Croatian (38) 38
Romanian (35) 35
Norwegian (32) 32
Slovak (30) 30
Turkish (27) 27
Bulgarian (26) 26
Swedish (26) 26
Hebrew (25) 25
Serbian (23) 23
Ukrainian (22) 22
Persian (18) 18
Finnish (14) 14
Lithuanian (5) 5
Slovenian (3) 3
Arabic (2) 2
Bosnian (2) 2
Icelandic (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The lancet oncology, ISSN 1470-2045, 2019, Volume 20, Issue 1, pp. 31 - 42
Journal Article
Rheumatology, ISSN 1462-0324, 04/2018, Volume 57, Issue suppl_3
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 1, pp. 35 - 47
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 6, pp. 520 - 531
This international prospective study showed that maintenance therapy with rituximab was more effective than interferon alfa in prolonging the duration of... 
SURVIVAL | FCM | MEDICINE, GENERAL & INTERNAL | THERAPY | PROSPECTIVE RANDOMIZED-TRIAL | CYCLOPHOSPHAMIDE | RITUXIMAB | COMBINATION | FLUDARABINE | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Lymphoma, Mantle-Cell - mortality | Aged, 80 and over | Female | Maintenance Chemotherapy | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Survival Rate | Vidarabine - analogs & derivatives | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Vidarabine - administration & dosage | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Care and treatment | Fludarabine | Mantle cell lymphoma | Aged patients | Dosage and administration | Product/Service Evaluations | Drug therapy | Health aspects | Clinical trials | Prednisone | Lymphoma | Doxorubicin | Patients | Vincristine | α-Interferon | Cyclophosphamide | Motivation | Remission | Lymphomas | Computer centers | Age | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 09/2013, Volume 98, Issue 9, pp. 3785 - 3792
Journal Article